UOC
CMRX

UBS O'Connor’s Chimerix, Inc. CMRX Stock Holding History

UBS O'Connor’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-210,000
Closed -$962K – 1016
2022
Q1 		$962K Buy
+210,000
New +$1.17M 0.01% 704

Other funds holding CMRX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS O'Connor's CMRX Position: Q2 2022 in Review

UBS O'Connor sold out of Chimerix, Inc. (CMRX) in Q2 2022, closing a stake of 210,000 shares — an estimated $962K sold.

UBS O'Connor first reported a position in CMRX in Q1 2022 and held it in 1 quarter. The position peaked at $962K in Q1 2022. 117 funds tracked by Wall St. Rank hold CMRX as of Q2 2022.

  • UBS O'Connor reported no remaining Chimerix, Inc. position as of Q2 2022 after selling out during the quarter.
  • UBS O'Connor sold 210,000 Chimerix, Inc. shares in Q2 2022, an estimated $962K.
  • UBS O'Connor first reported a position in Chimerix, Inc. in Q1 2022 and held it in 1 quarter.
  • UBS O'Connor's Chimerix, Inc. position peaked at $962K in Q1 2022.
  • 117 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2022.

Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.